Reactive polyarthritis induced by intravesical BCG therapy for carcinoma of the bladder
Xerri, B.; Chrétien, Y.; Le Parc, J.M.
European Journal of Medicine 2(8): 503-505
1993
ISSN/ISBN: 1165-0478 PMID: 8258055 Document Number: 407706
Document emailed within 1 workday
Related Documents
Nishino, Y.; Yasuda, M.; Yokoi, S.; Ehara, H.; Yamamoto, N.; Takahashi, Y.; Ishihara, S.; Deguchi, T.; Kawada, Y.; Takeda, A.; Sakai, S.; Takeuchi, T.; Taniguchi, M.; Minoshima, K.; Hamamoto, Y.; Kanimoto, Y.; Nakano, M.; Fujihiro, S.; Nezasa, S.; Matsuda, T.; Nagatani, Y.; Maeda, S.; Tamaki, M.; Saito, A.; Komeda, H. 1999: Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1869-1873Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Kanzler, S.; Gohlke, F.; Meyer Zum Büschenfelde, K.H.; Märker-Hermann, E. 1995: Therapy refractory atypical polyarthritis and cryoglobulinemia in a patient with colon carcinoma and palliative intestinal bypass. Differential diagnosis: carcinoma-polyarthritis or bypass arthritis Zeitschrift für Gastroenterologie 33(8): 449-453
Bouffioux, C. 1985: Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given? Progress in Clinical and Biological Research 185b: 47-55
Baselli, E.C.; Greenberg, R.E. 2000: Intravesical therapy for superficial bladder cancer Oncology 14(5): 719
Kinoshita, N.; Tochigi, H.; Yanagawa, M.; Yamakawa, K.; Sakurai, M.; Hioki, T.; Kawamura, J. 1990: Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside Hinyokika Kiyo. Acta Urologica Japonica 36(3): 257-263
Iemura, Y.; Fukui, S.; Matsumura, Y.; Kagebayashi, Y.; Toyoshima, Y.; Inoue, T.; Samma, S. 2018: Bladder Rupture during Intravesical BCG Therapy : A Case Report Hinyokika Kiyo. Acta Urologica Japonica 64(1): 25-28
Steg, A.; Belas, M.; Leleu, C.; Boccon-Gibod, L. 1989: Intravesical BCG therapy in patients with superficial bladder tumors Progress in Clinical and Biological Research 310(11): 153-160
Cao, M.; Ma, C.-k.; Ma, J.; Chen, H.-g.; Xue, W. 2011: Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer Zhonghua Zhong Liu Za Zhi 33(5): 385-387
Corcoran, A.T.; Gingrich, J.R. 2010: Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer? Oncology 24(12): 1161; 1166
Kob, D.; Lilienthal, A.; Bauhardt, H.; Merkle, K.; Schröder, E.; Schröder, E.; Hentschel, M. 1991: The radiation-sensitizing effect of isometronidazole following its intravesical application in bladder carcinoma. a clinical phase-Ii study Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 167(9): 530-533
Badalament, R.A.; Ortolano, V.; Burgers, J.K. 1992: Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy Urologic Clinics of North America 19(3): 485-498
Chen, S.; Lin, Z.; Ye, C.; Xu, E. 1996: Long-term results of intravesical N-CWS therapy for preventing bladder cancer recurrence after operation Chinese Medical Journal 109(11): 890-891
Cheng, C.W.; Lau, W.K.; Tan, P.H.; Olivo, M. 2000: Cystoscopic diagnosis of bladder cancer by intravesical instillation of 5-aminolevulinic acid induced porphyrin fluorescence--the Singapore experience Annals of the Academy of Medicine Singapore 29(2): 153-158
Huncharek, M.; McGarry, R.; Kupelnick, B. 2001: Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis Anticancer Research 21(1b): 765-769
Jakse, G. 1989: Intravesical instillation of BCG in carcinoma in situ of the urinary bladder. EORTC protocol 30861. EORTC-GU Group Progress in Clinical and Biological Research 310: 187-192
Punga-Maole, M.L.; Hubert, J.; Mangin, P. 1995: Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
Maier, U.; Kuber, W. 1983: Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors Fortschritte der Medizin 101(12): 535-540
Whelan, D.P. 2008: Words of wisdom. Re: predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the Surveillance, Epidemiology and End Results Programme (SEER) 2003 Patterns of Care Project European Urology 54(6): 1443-1444
Soma, I.; Hasuike, Y.; Hayashi, N.; Fukuchi, N.; Izawa, H.; Yoshida, T.; Ebisui, C.; Sakita, I.; Fujimoto, T.; Koshino, T.; Izumiyama, K. 2004: A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1903-1905